- This event has passed.
Sepsis Alliance Clinical Community Sponsor Innovation Day
March 9, 2022 @ 11:00 am - 2:30 pm
Date: March 9, 2022
Description: Join us for a day of expert sessions on innovations and best practices in sepsis care, each developed especially for the Sepsis Alliance Clinical Community by our sponsors. Each 30-minute session has its own registration link, so you can select those most applicable to your areas of focus—or join us for all four!
Topics include:
- Fluid management in sepsis;
- Machine learning data patterns;
- and more!
Keep reading to learn more about the individual sessions and to register.
Guess It or Assess It? Precise Fluid Resuscitation in Sepsis
Presented by Baxter
Time: 11:00 – 11:30 am ET / 8:00 – 8:30 am PT
Description: This session will discuss how to use the Passive Leg Raise test with stroke volume measurements to precisely predict fluid responsiveness in patients with sepsis.
CLICK HERE TO REGISTER
Informing Sepsis Care with Noninvasive Hemodynamic Optimization
Presented by Edwards Lifesciences
Time: 12:00 – 12:30 pm ET / 9:00 – 9:30 am PT
Description: Patients experiencing sepsis have unique underlying physiology that makes one-size-fits-all treatment protocols challenging. This discussion will cover how unveiling your patient’s hemodynamic profile can help support clinical decision making and support SEP-1 compliance. Learners will hear how noninvasive, continuous blood pressure and hemodynamic monitoring can be easily integrated into workflow through a case study.
CLICK HERE TO REGISTER
Helping Patients Avoid Sepsis Through Data Discovery
Presented by Dascena
Time: 1:00 – 1:30 pm ET / 10:00 – 10:30 am PT
Description: Dascena’s machine learning algorithm, InSight, is a non-device clinical decision support (CDS) tool used by healthcare providers to identify patient data patterns that may be missed by a human. InSight can automatically recognize patients who are at risk of sepsis up to 4 hours before onset with high accuracy. This helps inform physicians and care teams early, so they can take appropriate action.
Clinical evidence and scientific rigor are at the core of Dascena’s development. During our real-world clinical trial, hospitals saw an average 39.5% reduction of in-hospital mortality, a 32.3% reduction of hospital length of stay, and a 22.7% reduction of 30-day readmission rates for sepsis-related patient stays when using InSight.
CLICK HERE TO REGISTER
Invasive Extraintestinal Pathogenic Escherichia coli Disease (IED): An Unknown Burden
Presented by Janssen
Time: 2:00 – 2:30 pm ET / 11:00 – 11:30 am PT
Description: In this webinar, learn about the etiology, epidemiology, and clinical manifestations of Extraintestinal Pathogenic Escherichia coli (ExPEC) Disease (IED). The presenter will describe the relationship between E. coli infection and sepsis, and will explain how infection control practices and vaccines can help prevent bacterial infections.
CLICK HERE TO REGISTER
